LCG
PRDS

Luxor Capital Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Luxor Capital Group’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,288
Closed -$112K – 133
2021
Q1 		$112K Buy
+11,288
New +$112K ﹤0.01% 110